Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Marije E. Otto

19 indexed publications match this author name.

ORCID: 0000-0002-5767-604X
OpenAlex: https://openalex.org/A5055275304

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Pharmacology 10 Receptor Pharmacology 9 Depression 6 Mechanism of Action 5 Animal Study 5 Toxicity 5 Safety 4 Review Article 4 Anxiety 3 Chronic Pain 3 Clinical Trial 3 Systematic Review 3

Journals

Journal of Psychopharmacology 3 bioRxiv 2 Digestive and Liver Disease 2 Translational Psychiatry 1 JAMA Network Open 1 BMJ Supportive & Palliative Care 1 Repository for Publications and Research Data (ETH Zurich) 1 Clinical Neuropsychopharmacology and Addiction 1

Publication history

Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23 Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06 Effects of psychedelic use on authoritarian attitudes revisitedJournal of Psychopharmacology · 2026-04-30 Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant EffectsbioRxiv · 2026-04-21 Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybinbioRxiv · 2026-03-03 Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative reviewBMJ Supportive & Palliative Care · 2026-02-17 Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19 A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteerJournal of Psychopharmacology · 2025-10-15 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24 Lifetime classic psychedelic use and headaches: A cross-sectional studyJournal of Psychopharmacology · 2025-03-11 Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.Unknown journal · 2025-02-28 Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.Unknown journal · 2025-01-14 THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31 Development of a digital intervention for psychedelic preparation (DIPP)Scientific Reports · 2024-02-18 Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31 Psychedelics promote plasticity by directly binding to BDNF receptor TrkBNature Neuroscience · 2023-05-31 A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic HealingJournal of Humanistic Psychology · 2021-09-15 The quantitation of psilocybin in hallucinogenic mushrooms using high performance liquid chromatography.Unknown journal · 1983-09-30

Author directory